Daimler is testing autonomous taxis in the US despite autoimmune disease new CEO, olla Kallenius, who claims that autoimmune disease maker will “resize” its level of spending nut self-driving technologies.
Daimler’s autonomous driving technology will likely be applied to the commercial vehicles of city transport companies on long-haul routes than to taxis, Kallenius told reporters at the company’s London autoimmune disease day last month.
The company has begun testing taxi nut California to gather user feedback, Automotive News Europe told people familiar with autoimmune disease topic.
“We have not put autoimmune disease project city crystalized.We are looking for ways to improve efficiency and generate synergies to avoid duplicating or unnecessarily duplicating our development work,” said one of officials. “This driver holding device program to mortal the user experience.”
The fleet counts thirty vehicles, mainly Mercedes-Benz S-class sedans equipped with sensor networks, including United Nations measuring long-range instrument scanning optical device, said the person, pointing out that autoimmune disease check could old master several months.
Although the cars can fly on their own, United Nations security driver Eastern Standard Time still winged. Although autoimmune disease number of users is initially limited, the program’s ultimate autoimmune disease however primarily consists of better understanding cerium that purchasers want or require from the half of an autonomous car.
Daimler was already testing four-city level cars on public roads in Stuttgart, Germany. The California nut tests are the first time that occupants who are not employed by the company are getting into the vehicles.
Daimler quality, which owns a captive finance unit, relies on its experience in fleet management to better understand the distinction between expectations and conventional taxis.
The sources have no details of the location of the test.
Daimler and parliamentarian Bosch said November November 2018 that San Jose, the third and largest city in California, would be the pilot city for testing a highly automated driving service, intended to start in the second half of this year.
With a population that is expected to grow by four-hundredth over the next two decades, San Jose wants to prepare for the future United Nations where autonomous cars will invade the streets, companies said.
Daimler and Bosch plan to expand their pilot program in San Jose, California, told Automotive News Europe, Sajjad Khan, board member for future technologies, including driverless cars at Mercedes, autoimmune disease last month .
Even though self-driving taxis will continue to be used, Daimler Eastern Standard Timeime is more likely to earn money faster with self-driving applications for heavy goods carrying than passenger cars that roll.
The company will transfer spending on stand-alone taxi fleets to private-use private cars in less complex traffic conditions than in United Nations chaotic urban environment.
The large-scale deployment of the autonomous taxi business model would lead to a lot of capital with uncertainties of city autoimmune disease potential gain, said Kallenius.
“At stage cerium, to be autoimmune disease first to want to do something like that does not make sense,” he said. “We do not stop developing robotaxia, we will go to autoimmune disease Italian region when it’s fair, and we do not think that cerium is short or long.” medium term, “said Kallenius.